Google, AHA create a $50M heart drug collaboration

Google Life Sciences ($GOOG) joined the American Heart Association in creating a new $50 million research initiative to find better heart drugs. The groups hope that a multidisciplinary approach to research can do a better job in discovering new cardio therapies, which remains a major challenge as biotechs assess the cost of developing new heart remedies. Story

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.